Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

التفاصيل البيبلوغرافية
العنوان:	Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
المؤلفون:	Holmsten, K, Jensen, NV, Mouritsen, LS, Jonsson, E, Mellnert, C, Agerbaek, M, Nilsson, C, Moe, M, Carus, A, Ofverholm, E, Lahdenpera, O, Brandberg, Y, Johansson, H, Hellstrom, M, von der Maase, H, Pappot, H, Ullen, A
المصدر:	European journal of cancer (Oxford, England : 1990). 127:173-182
مصطلحات موضوعية:	Medicin och hälsovetenskap
الوصول الحر:	http://kipublications.ki.se/Default.aspx?queryparsed=id:143209762Test
قاعدة البيانات:	SwePub

الوصف
تدمد:	18790852
DOI:	10.1016/j.ejca.2019.08.033